• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环丙沙星注射液在腹膜透析液中的稳定性。

Stability of ciprofloxacin injection in peritoneal dialysis solutions.

作者信息

Kane M P, Bailie G R, Moon D G, Siu I

机构信息

Department of Pharmacy Practice, Albany College of Pharmacy, Union University, NY 12208.

出版信息

Am J Hosp Pharm. 1994 Feb 1;51(3):373-7.

PMID:8160691
Abstract

The stability of ciprofloxacin 25 mg/L in peritoneal dialysis solutions containing 1.5% and 4.25% dextrose after storage at 4 degrees C for two weeks, 25 degrees C for one week, or 37 degrees C for two days was evaluated. Ciprofloxacin 50 mg was added to 18 2-L bags of peritoneal dialysis solutions, nine containing 1.5% dextrose and nine containing 4.25% dextrose. Three bags of each dialysis solution were stored at 4 degrees C for 14 days, 25 degrees C for 7 days, and 37 degrees C for 2 days. Samples were drawn from each bag, and ciprofloxacin concentrations were measured by high-performance liquid chromatography. Stability was defined as less than 10% decrease from initial concentration. In the solution containing 1.5% dextrose, 87.2% of the ciprofloxacin remained after 14 days of storage at 4 degrees C, 93.4% remained after 7 days of storage at 25 degrees C, and 95.2% remained after 2 days of storage at 37 degrees C. In the solution containing 4.25% dextrose, 89.0% of the ciprofloxacin remained after 14 days of storage at 4 degrees C, 93.7% remained after 7 days of storage at 25 degrees C, and 97.8% remained after 2 days of storage at 37 degrees C. In peritoneal dialysis solutions containing 1.5% and 4.25% dextrose, ciprofloxacin was stable for seven days at 25 degrees C and for 48 hours at 37 degrees C. Ciprofloxacin concentrations after two weeks at 4 degrees C were below 90% of initial concentration.

摘要

评估了25毫克/升环丙沙星在含1.5%和4.25%葡萄糖的腹膜透析液中,于4℃储存两周、25℃储存一周或37℃储存两天后的稳定性。将50毫克环丙沙星加入18袋2升的腹膜透析液中,其中9袋含1.5%葡萄糖,9袋含4.25%葡萄糖。每种透析液的三袋分别在4℃储存14天、25℃储存7天、37℃储存2天。从每袋中取样,通过高效液相色谱法测定环丙沙星浓度。稳定性定义为浓度较初始浓度降低少于10%。在含1.5%葡萄糖的溶液中,4℃储存14天后87.2%的环丙沙星留存,25℃储存7天后93.4%留存,37℃储存2天后95.2%留存。在含4.25%葡萄糖的溶液中,4℃储存14天后89.0%的环丙沙星留存,25℃储存7天后93.7%留存,37℃储存2天后97.8%留存。在含1.5%和4.25%葡萄糖的腹膜透析液中,环丙沙星在25℃下稳定7天,在37℃下稳定48小时。4℃储存两周后的环丙沙星浓度低于初始浓度的90%。

相似文献

1
Stability of ciprofloxacin injection in peritoneal dialysis solutions.环丙沙星注射液在腹膜透析液中的稳定性。
Am J Hosp Pharm. 1994 Feb 1;51(3):373-7.
2
Stability of ciprofloxacin in peritoneal dialysis solution.
Am J Hosp Pharm. 1992 Dec;49(12):2956-9.
3
Stability of cefazolin sodium in peritoneal dialysis solutions.头孢唑林钠在腹膜透析液中的稳定性。
Am J Hosp Pharm. 1991 Feb;48(2):291-2.
4
Stability of cefotaxime in two peritoneal dialysis solutions.头孢噻肟在两种腹膜透析液中的稳定性。
Am J Hosp Pharm. 1990 Jan;47(1):147-50.
5
Stability of dobutamine hydrochloride in peritoneal dialysis solutions.
Am J Hosp Pharm. 1991 Jun;48(6):1234-7.
6
Stability of moxifloxacin injection in peritoneal dialysis solution bags (Dianeal PD1 1.36% and Dianeal PD1 3.86%).莫西沙星注射液在腹膜透析液袋(百特1.36%腹膜透析液和百特3.86%腹膜透析液)中的稳定性
J Clin Pharm Ther. 2006 Dec;31(6):641-3. doi: 10.1111/j.1365-2710.2006.00758.x.
7
Storage of lorazepam in three injectable solutions in polyvinyl chloride and polyolefin bags.劳拉西泮在聚氯乙烯袋和聚烯烃袋中的三种注射用溶液中的储存情况。
Am J Hosp Pharm. 1994 Feb 1;51(3):368-72.
8
Compatibility of ciprofloxacin injection with selected drugs and solutions.
Am J Hosp Pharm. 1991 Oct;48(10):2166-71.
9
Stability of an ofloxacin injection in various infusion fluids.氧氟沙星注射液在各种输液中的稳定性。
Am J Hosp Pharm. 1992 Nov;49(11):2756-60.
10
Stability of dobutamine hydrochloride and verapamil hydrochloride in 0.9% sodium chloride and 5% dextrose injections.盐酸多巴酚丁胺与盐酸维拉帕米在0.9%氯化钠注射液和5%葡萄糖注射液中的稳定性
Am J Hosp Pharm. 1984 Apr;41(4):686-9.

引用本文的文献

1
Integration of dual drugs into a collagen scaffold by a combination of apatite coating and impregnation with apatite particles for periodontal regeneration.通过磷灰石涂层和磷灰石颗粒浸渍相结合的方法将双药整合到胶原支架中用于牙周再生。
RSC Adv. 2025 Jun 9;15(24):19480-19488. doi: 10.1039/d5ra02963e. eCollection 2025 Jun 4.
2
Compatibility of ciprofloxacin with commercial peritoneal dialysis solutions.环丙沙星与商业腹膜透析液的相容性。
Sci Rep. 2019 Apr 24;9(1):6512. doi: 10.1038/s41598-019-42854-y.